Corvus Pharmaceuticals (CRVS) Current Leases: 2022-2025
Historic Current Leases for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Sep 2025 value amounting to $379,000.
- Corvus Pharmaceuticals' Current Leases rose 7.06% to $379,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $379,000, marking a year-over-year increase of 7.06%. This contributed to the annual value of $185,000 for FY2024, which is 86.54% down from last year.
- According to the latest figures from Q3 2025, Corvus Pharmaceuticals' Current Leases is $379,000, which was up 6.76% from $355,000 recorded in Q2 2025.
- Corvus Pharmaceuticals' Current Leases' 5-year high stood at $1.4 million during Q4 2023, with a 5-year trough of $185,000 in Q4 2024.
- Moreover, its 3-year median value for Current Leases was $700,000 (2024), whereas its average is $782,182.
- Per our database at Business Quant, Corvus Pharmaceuticals' Current Leases climbed by 15.87% in 2023 and then crashed by 86.54% in 2024.
- Over the past 4 years, Corvus Pharmaceuticals' Current Leases (Quarterly) stood at $1.2 million in 2022, then climbed by 11.89% to $1.4 million in 2023, then slumped by 86.54% to $185,000 in 2024, then increased by 7.06% to $379,000 in 2025.
- Its Current Leases stands at $379,000 for Q3 2025, versus $355,000 for Q2 2025 and $319,000 for Q1 2025.